PUBLISHER: The Insight Partners | PRODUCT CODE: 1873990
PUBLISHER: The Insight Partners | PRODUCT CODE: 1873990
The Automated Compounding Systems Market was valued at approximately US$ 520.48 million in 2024 and is projected to be US$ 950.41 million by 2031, reflecting a compound annual growth rate (CAGR) of 8.0% through 2031. Key trends in the Automated Compounding Systems Market are anticipated to include strategic developments and new product launches.
Analysis of the Automated Compounding Systems Market
The growth of the automated compounding systems market is driven by the rising demand for personalized medicine, enhanced patient safety, strict regulations governing medication compounding, the efficiency and cost-effectiveness of automated systems, and growing awareness among pharmacists. Additionally, the increasing prevalence of chronic diseases has further stimulated the demand for these systems.
Overview of the Automated Compounding Systems Market
Automated compounding systems are designed to minimize medication errors that can arise from various factors, including poor communication between physicians and pharmacists, inadequate storage practices in pharmacies, and confusion caused by similar labeling. These systems enhance the accuracy and efficiency of dispensing compounded medications while also reducing healthcare professionals' exposure to hazardous substances.
Strategic Insights
Drivers and Opportunities in the Automated Compounding Systems Market
Growing Need to Reduce Medication Errors
Medication and dispensing errors are significant contributors to hospital readmissions globally. Such errors can occur at multiple levels of patient care by both medical and paramedical staff. Factors leading to medication errors include poor communication of orders between doctors and pharmacists, unsafe storage practices in pharmacies, and misunderstandings due to similar labels. Therefore, comprehensive monitoring is essential. Automated compounding systems are recognized as effective solutions to reduce these errors. Various governmental bodies are implementing measures to prevent medication errors and are developing systems to ensure proper medication delivery to patients. Consequently, the promotion of automated compounding and medication tools in pharmacies and hospitals by governments is a crucial factor driving the growth of the automated compounding systems market.
Opportunities for Automated Compounding Systems in Parenteral Nutrition
Parenteral nutrition is necessary for patients unable to meet their nutritional needs due to conditions like cancer and chronic gastrointestinal diseases. This form of nutrition is vital for many patients suffering from severe short bowel syndrome (SBS), which affects approximately 3 individuals per million annually. According to a 2020 article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," the prevalence of SBS has more than doubled over the past 40 years, with around 30 cases per million in the US and about 1.4 cases per million in Europe. Automated compounding systems can be utilized to produce parenteral nutrition products, often linked to specialized software that electronically transmits information regarding PN formulations. Ongoing research comparing PN formulations created by automated systems versus manual methods is expected to present growth opportunities for the automated compounding systems market.
Key segments contributing to the analysis of the Automated Compounding Systems Market include route of administration, application, and end user.
Geographical Analysis of the Automated Compounding Systems Market
The geographical scope of the Automated Compounding Systems Market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America leads the Automated Compounding Systems Market, driven by the rising demand for medications for chronic diseases, the presence of major market players, an increase in product launches, and the growing adoption of automated compounding systems in the US. Additionally, the rise in pharmaceutical production is boosting the demand for automated filling and packaging of medications, alongside extensive R&D efforts by academic institutions and pharmaceutical companies. Furthermore, the Asia Pacific region is expected to exhibit the highest CAGR in the coming years.
Scope of the Automated Compounding Systems Market Report
Recent Developments in the Automated Compounding Systems Market
The evaluation of the Automated Compounding Systems Market is based on qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the automated compounding systems market include:
Coverage and Deliverables of the Automated Compounding Systems Market Report
The report titled "Automated Compounding Systems Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas: